In the last 12 months, insiders at Altimmune, Inc. ($ALT) filed 254 transactions with the SEC: 15 open-market purchases totaling $476,851 and 3 sales totaling $151,257. Net insider sentiment: net buying.
Altimmune, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Garg Vipin K (President and CEO) — 37 transactions totaling $871,414
- Roberts M Scot (Chief Scientific Officer) — 54 transactions totaling $362,028
- Harris Matthew Scott (Chief Medical Officer) — 41 transactions totaling $311,144
- Garg Vipin K (Not found) — 10 transactions totaling $295,924
- Drutz David (Director) — 9 transactions totaling $256,215
View all SEC Filings for Altimmune, Inc. (ALT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Durso Jerome Benedict | President and CEO | P | Common Stock, par value $0.0001 | 15000 | $3.14 | 47,500.0000 | 88,104,132 | 46.15% | 0.02% |
| April 1, 2026 | WEAVER GREGORY L | Chief Financial Officer | P | Common Stock, par value $0.0001 | 10000 | $3.15 | 38,078.0000 | 88,104,132 | 35.62% | 0.01% |
| March 6, 2026 | WEAVER GREGORY L | Chief Financial Officer | P | Common Stock, par value $0.0001 | 5000 | $3.54 | 28,078.0000 | 88,104,132 | 21.67% | 0.01% |
| March 6, 2026 | Durso Jerome Benedict | President and CEO | P | Common Stock, par value $0.0001 | 20000 | $3.54 | 32,500.0000 | 88,104,132 | 160.00% | 0.02% |
| Feb. 26, 2026 | Roberts M Scot | Chief Scientific Officer | A | Stock Options (option to buy) | 222670 | $0.00 | 222,670.0000 | 88,104,132 | 9999.99% | 0.25% |
| Feb. 26, 2026 | WEAVER GREGORY L | Chief Financial Officer | A | Restricted Stock Units | 111000 | $0.00 | 111,000.0000 | 88,104,132 | 9999.99% | 0.13% |
| Feb. 26, 2026 | WEAVER GREGORY L | Chief Financial Officer | A | Stock Options (option to buy) | 259000 | $0.00 | 259,000.0000 | 88,104,132 | 9999.99% | 0.29% |
| Feb. 26, 2026 | Roberts M Scot | Chief Scientific Officer | A | Restricted Stock Units | 95430 | $0.00 | 95,430.0000 | 88,104,132 | 9999.99% | 0.11% |
| Jan. 30, 2026 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 9275 | $0.00 | 9,275.0000 | 88,104,132 | 50.00% | 0.01% |
| Feb. 2, 2026 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2329 | $5.55 | 112,824.0000 | 88,104,132 | 2.02% | 0.00% |
| Feb. 2, 2026 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 7775 | $0.00 | 0.0000 | 88,104,132 | 100.00% | 0.01% |
| Feb. 2, 2026 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 115,153.0000 | 88,104,132 | 7.24% | 0.01% |
| Jan. 31, 2026 | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 5567 | $3.07 | 107,378.0000 | 88,104,132 | 5.47% | 0.01% |
| Jan. 30, 2026 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2859 | $5.60 | 101,811.0000 | 88,104,132 | 2.73% | 0.00% |
| Jan. 30, 2026 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 9275 | $0.00 | 104,670.0000 | 88,104,132 | 9.72% | 0.01% |
| Jan. 31, 2026 | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 4571 | $3.07 | 70,107.0000 | 88,104,132 | 6.97% | 0.01% |
| Jan. 31, 2026 | Garg Vipin K | Not found | A | Common Stock, par value $0.0001 | 6926 | $3.07 | 424,519.0000 | 88,104,132 | 1.66% | 0.01% |
| Jan. 30, 2026 | Garg Vipin K | Not found | F | Common Stock, par value $0.0001 | 11632 | $5.60 | 417,593.0000 | 88,104,132 | 2.71% | 0.01% |
| Jan. 30, 2026 | Garg Vipin K | Not found | M | Restricted Stock Units | 26775 | $0.00 | 26,775.0000 | 88,104,132 | 50.00% | 0.03% |
| Jan. 30, 2026 | Garg Vipin K | Not found | M | Common Stock, par value $0.0001 | 26775 | $0.00 | 429,225.0000 | 88,104,132 | 6.65% | 0.03% |
| Jan. 27, 2026 | Garg Vipin K | Not found | M | Restricted Stock Units | 41200 | $0.00 | 123,600.0000 | 88,104,132 | 25.00% | 0.05% |
| Jan. 27, 2026 | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 15850 | $0.00 | 69,765.0000 | 88,104,132 | 29.40% | 0.02% |
| Jan. 27, 2026 | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 4229 | $6.18 | 65,536.0000 | 88,104,132 | 6.06% | 0.00% |
| Jan. 27, 2026 | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 15850 | $0.00 | 47,550.0000 | 88,104,132 | 25.00% | 0.02% |
| Jan. 27, 2026 | Garg Vipin K | Not found | M | Common Stock, par value $0.0001 | 41200 | $0.00 | 420,348.0000 | 88,104,132 | 10.87% | 0.05% |
| Jan. 27, 2026 | Garg Vipin K | Not found | F | Common Stock, par value $0.0001 | 17898 | $6.18 | 402,450.0000 | 88,104,132 | 4.26% | 0.02% |
| Jan. 27, 2026 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 15850 | $0.00 | 100,143.0000 | 88,104,132 | 18.80% | 0.02% |
| Jan. 27, 2026 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 4748 | $6.18 | 95,395.0000 | 88,104,132 | 4.74% | 0.01% |
| Jan. 27, 2026 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 15850 | $0.00 | 47,550.0000 | 88,104,132 | 25.00% | 0.02% |
| Jan. 25, 2026 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 14600 | $0.00 | 29,200.0000 | 88,104,132 | 33.33% | 0.02% |
| Jan. 25, 2026 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 4373 | $5.50 | 84,293.0000 | 88,104,132 | 4.93% | 0.00% |
| Jan. 25, 2026 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 14600 | $0.00 | 88,666.0000 | 88,104,132 | 19.71% | 0.02% |
| Jan. 25, 2026 | Garg Vipin K | Not found | M | Restricted Stock Units | 42050 | $0.00 | 84,100.0000 | 88,104,132 | 33.33% | 0.05% |
| Jan. 25, 2026 | Garg Vipin K | Not found | F | Common Stock, par value $0.0001 | 17984 | $5.50 | 379,148.0000 | 88,104,132 | 4.53% | 0.02% |
| Jan. 25, 2026 | Garg Vipin K | Not found | M | Common Stock, par value $0.0001 | 42050 | $0.00 | 397,132.0000 | 88,104,132 | 11.84% | 0.05% |
| Jan. 25, 2026 | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 14600 | $0.00 | 29,200.0000 | 88,104,132 | 33.33% | 0.02% |
| Jan. 25, 2026 | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 3855 | $5.50 | 53,915.0000 | 88,104,132 | 6.67% | 0.00% |
| Jan. 25, 2026 | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 14600 | $0.00 | 57,770.0000 | 88,104,132 | 33.82% | 0.02% |
| Jan. 8, 2026 | Pisano Wayne | Not found | P | Common Stock, par value $0.0001 | 5000 | $4.08 | 13,498.0000 | 88,104,132 | 58.84% | 0.01% |
| Jan. 1, 2026 | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 9375 | $0.00 | 45,645.0000 | 88,104,132 | 25.85% | 0.01% |
| Jan. 1, 2026 | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 2475 | $3.61 | 43,170.0000 | 88,104,132 | 5.42% | 0.00% |
| Jan. 5, 2026 | Sohn Catherine A. | Not found | P | Common Stock, par value $0.0001 | 500 | $4.24 | 1,500.0000 | 88,104,132 | 50.00% | 0.00% |
| Jan. 1, 2026 | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 9375 | $0.00 | 9,375.0000 | 88,104,132 | 50.00% | 0.01% |
| Dec. 29, 2025 | Jorkasky Diane | Not found | P | Common Stock, par value $0.0001 | 527 | $3.80 | 527.0000 | 89,418,028 | 9999.99% | 0.00% |
| Dec. 23, 2025 | GILL JOHN | Not found | P | Common Stock, par value $0.0001 | 12500 | $4.10 | 12,500.0000 | 89,418,028 | 9999.99% | 0.01% |
| Dec. 22, 2025 | Durso Jerome Benedict | Not found | P | Common Stock, par value $0.0001 | 12500 | $4.13 | 12,500.0000 | 89,418,028 | 9999.99% | 0.01% |
| Dec. 1, 2025 | Durso Jerome Benedict | CEO-elect | A | Restricted Stock Units | 633700 | $0.00 | 633,700.0000 | 89,418,028 | 9999.99% | 0.71% |
| Dec. 1, 2025 | Durso Jerome Benedict | CEO-elect | A | Stock Options (option to buy) | 1824400 | $0.00 | 1,824,400.0000 | 89,418,028 | 9999.99% | 2.04% |
| Nov. 11, 2025 | WEAVER GREGORY L | Chief Financial Officer | M | Common Stock, par value $0.0001 | 18750 | $0.00 | 28,750.0000 | 89,418,028 | 187.50% | 0.02% |
| Nov. 11, 2025 | WEAVER GREGORY L | Chief Financial Officer | M | Restricted Stock Units | 18750 | $0.00 | 56,250.0000 | 89,418,028 | 25.00% | 0.02% |
| Nov. 11, 2025 | WEAVER GREGORY L | Chief Financial Officer | F | Common Stock, par value $0.0001 | 5672 | $4.28 | 23,078.0000 | 89,418,028 | 19.73% | 0.01% |
| Oct. 1, 2025 | WEAVER GREGORY L | Chief Financial Officer | A | Restricted Stock Units | 57900 | $0.00 | 57,900.0000 | 89,418,028 | 9999.99% | 0.06% |
| Oct. 1, 2025 | Arbet-Engels Christophe | Chief Medical Officer | A | Restricted Stock Units | 150000 | $0.00 | 150,000.0000 | 89,418,028 | 9999.99% | 0.17% |
| Oct. 1, 2025 | Arbet-Engels Christophe | Chief Medical Officer | A | Stock Options (option to buy) | 450000 | $0.00 | 450,000.0000 | 89,418,028 | 9999.99% | 0.50% |
| Oct. 1, 2025 | WEAVER GREGORY L | Chief Financial Officer | A | Stock Options (option to buy) | 166800 | $0.00 | 166,800.0000 | 89,418,028 | 9999.99% | 0.19% |
| Sept. 25, 2025 | Lawver Teri L | Director | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 81,477,548 | 9999.99% | 0.06% |
| Sept. 25, 2025 | Sohn Catherine A. | Director | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 81,477,548 | 9999.99% | 0.06% |
| Sept. 25, 2025 | Durso Jerome Benedict | Director | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 81,477,548 | 9999.99% | 0.06% |
| Sept. 25, 2025 | Jorkasky Diane | Director | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 81,477,548 | 9999.99% | 0.06% |
| Jan. 6, 2022 | GILL JOHN | Director | G | Common Stock, par value $0.0001 | 2714 | $0.00 | 0.0000 | 41,283,498 | 100.00% | 0.01% |
| Sept. 25, 2025 | GILL JOHN | Director | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 81,477,548 | 9999.99% | 0.06% |
| Sept. 25, 2025 | Schafer Klaus | Director | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 81,477,548 | 9999.99% | 0.06% |
| Sept. 25, 2025 | SAYARE MITCHEL | Director | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 81,477,548 | 9999.99% | 0.06% |
| Sept. 25, 2025 | Hodges Philip | Director | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 81,477,548 | 9999.99% | 0.06% |
| Sept. 25, 2025 | Pisano Wayne | Director | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 81,477,548 | 9999.99% | 0.06% |
| Sept. 16, 2025 | Richardson Linda M | Chief Commercial Officer | A | Restricted Stock Units | 96000 | $0.00 | 96,000.0000 | 81,477,548 | 9999.99% | 0.12% |
| Sept. 16, 2025 | Richardson Linda M | Chief Commercial Officer | A | Stock Options (option to buy) | 278000 | $0.00 | 278,000.0000 | 81,477,548 | 9999.99% | 0.34% |
| July 31, 2025 | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 846 | $3.14 | 74,066.0000 | 81,477,548 | 1.16% | 0.00% |
| July 31, 2025 | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 1368 | $3.14 | 36,270.0000 | 81,477,548 | 3.92% | 0.00% |
| July 31, 2025 | Harris Matthew Scott | Chief Medical Officer | A | Common Stock, par value $0.0001 | 2018 | $3.14 | 83,874.0000 | 81,477,548 | 2.47% | 0.00% |
| March 17, 2025 | Sohn Catherine A. | Director | P | Common Stock, par value $0.0001 | 1000 | $5.78 | 1,000.0000 | 71,003,399 | 9999.99% | 0.00% |
| March 13, 2025 | WEAVER GREGORY L | Chief Financial Officer | P | Common Stock, par value $0.0001 | 10000 | $5.20 | 10,000.0000 | 71,003,399 | 9999.99% | 0.01% |
| March 7, 2025 | Harris Matthew Scott | Chief Medical Officer | G | Common Stock, par value $0.0001 | 67787 | $0.00 | 81,856.0000 | 71,003,399 | 45.30% | 0.10% |
| Feb. 24, 2025 | Lawver Teri L | Director | A | Stock Options (option to buy) | 69800 | $0.00 | 69,800.0000 | 71,003,399 | 9999.99% | 0.10% |
| Feb. 24, 2025 | Durso Jerome Benedict | Director | A | Stock Options (option to buy) | 69800 | $0.00 | 69,800.0000 | 71,003,399 | 9999.99% | 0.10% |
| Feb. 6, 2025 | Sohn Catherine A. | Director | A | Stock Options (option to buy) | 18600 | $0.00 | 18,600.0000 | 71,003,399 | 9999.99% | 0.03% |
| Jan. 30, 2025 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2709 | $7.00 | 60,212.0000 | 71,003,399 | 4.31% | 0.00% |
| Jan. 30, 2025 | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 26775 | $0.00 | 342,696.0000 | 71,003,399 | 8.48% | 0.04% |
| Jan. 30, 2025 | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 11701 | $7.00 | 330,995.0000 | 71,003,399 | 3.41% | 0.02% |
| Jan. 31, 2025 | Garg Vipin K | President and CEO | A | Common Stock, par value $0.0001 | 4105 | $5.18 | 335,100.0000 | 71,003,399 | 1.24% | 0.01% |
| Feb. 1, 2025 | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 16545 | $0.00 | 351,645.0000 | 71,003,399 | 4.94% | 0.02% |
| Feb. 1, 2025 | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 7231 | $6.64 | 344,414.0000 | 71,003,399 | 2.06% | 0.01% |
| Feb. 2, 2025 | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 18950 | $0.00 | 363,364.0000 | 71,003,399 | 5.50% | 0.03% |
| Feb. 2, 2025 | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 8282 | $6.64 | 355,082.0000 | 71,003,399 | 2.28% | 0.01% |
| Jan. 30, 2025 | Garg Vipin K | President and CEO | M | Restricted Stock Units | 26775 | $0.00 | 53,550.0000 | 71,003,399 | 100.00% | 0.04% |
| Feb. 1, 2025 | Garg Vipin K | President and CEO | M | Restricted Stock Units | 16545 | $0.00 | 0.0000 | 71,003,399 | 0.00% | 0.02% |
| Feb. 2, 2025 | Garg Vipin K | President and CEO | M | Restricted Stock Units | 18950 | $0.00 | 18,950.0000 | 71,003,399 | 9999.99% | 0.03% |
| Jan. 30, 2025 | Harris Matthew Scott | Chief Medical Officer | M | Common Stock, par value $0.0001 | 9275 | $0.00 | 74,000.0000 | 71,003,399 | 14.33% | 0.01% |
| Jan. 30, 2025 | Harris Matthew Scott | Chief Medical Officer | F | Common Stock, par value $0.0001 | 3173 | $7.00 | 70,827.0000 | 71,003,399 | 4.29% | 0.00% |
| Jan. 31, 2025 | Harris Matthew Scott | Chief Medical Officer | A | Common Stock, par value $0.0001 | 1905 | $5.18 | 72,732.0000 | 71,003,399 | 2.69% | 0.00% |
| Feb. 1, 2025 | Harris Matthew Scott | Chief Medical Officer | M | Common Stock, par value $0.0001 | 6166 | $0.00 | 78,898.0000 | 71,003,399 | 8.48% | 0.01% |
| Feb. 1, 2025 | Harris Matthew Scott | Chief Medical Officer | F | Common Stock, par value $0.0001 | 2109 | $6.64 | 76,789.0000 | 71,003,399 | 2.67% | 0.00% |
| Feb. 2, 2025 | Harris Matthew Scott | Chief Medical Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 84,564.0000 | 71,003,399 | 10.13% | 0.01% |
| Feb. 2, 2025 | Harris Matthew Scott | Chief Medical Officer | F | Common Stock, par value $0.0001 | 2708 | $6.64 | 81,856.0000 | 71,003,399 | 3.20% | 0.00% |
| Jan. 30, 2025 | Harris Matthew Scott | Chief Medical Officer | M | Restricted Stock Units | 9275 | $0.00 | 18,550.0000 | 71,003,399 | 100.00% | 0.01% |
| Feb. 1, 2025 | Harris Matthew Scott | Chief Medical Officer | M | Restricted Stock Units | 6166 | $0.00 | 0.0000 | 71,003,399 | 0.00% | 0.01% |
| Feb. 2, 2025 | Harris Matthew Scott | Chief Medical Officer | M | Restricted Stock Units | 7775 | $0.00 | 7,775.0000 | 71,003,399 | 9999.99% | 0.01% |
| Jan. 31, 2025 | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 2614 | $5.18 | 34,902.0000 | 71,003,399 | 8.10% | 0.00% |
| Jan. 30, 2025 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 9275 | $0.00 | 62,921.0000 | 71,003,399 | 17.29% | 0.01% |
| Jan. 31, 2025 | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 3184 | $5.18 | 63,396.0000 | 71,003,399 | 5.29% | 0.00% |
| Feb. 1, 2025 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 6166 | $0.00 | 69,562.0000 | 71,003,399 | 9.73% | 0.01% |
| Feb. 1, 2025 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 1801 | $6.64 | 67,761.0000 | 71,003,399 | 2.59% | 0.00% |
| Feb. 2, 2025 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 75,536.0000 | 71,003,399 | 11.47% | 0.01% |
| Feb. 2, 2025 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2316 | $6.64 | 73,220.0000 | 71,003,399 | 3.07% | 0.00% |
| Jan. 30, 2025 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 9275 | $0.00 | 18,550.0000 | 71,003,399 | 100.00% | 0.01% |
| Feb. 1, 2025 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 6166 | $0.00 | 0.0000 | 71,003,399 | 0.00% | 0.01% |
| Feb. 2, 2025 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 7775 | $0.00 | 7,775.0000 | 71,003,399 | 9999.99% | 0.01% |
| Jan. 27, 2025 | Harris Matthew Scott | Chief Medical Officer | A | Stock Options (option to buy) | 183600 | $0.00 | 183,600.0000 | 71,003,399 | 9999.99% | 0.26% |
| Jan. 25, 2025 | Harris Matthew Scott | Chief Medical Officer | F | Common Stock, par value $0.0001 | 4994 | $6.98 | 64,725.0000 | 71,003,399 | 7.16% | 0.01% |
| Jan. 25, 2025 | Harris Matthew Scott | Chief Medical Officer | M | Restricted Stock Units | 14600 | $0.00 | 43,800.0000 | 71,003,399 | 50.00% | 0.02% |
| Jan. 27, 2025 | Harris Matthew Scott | Chief Medical Officer | A | Restricted Stock Units | 63400 | $0.00 | 63,400.0000 | 71,003,399 | 9999.99% | 0.09% |
| Jan. 27, 2025 | Garg Vipin K | President and CEO | A | Restricted Stock Units | 164800 | $0.00 | 164,800.0000 | 71,003,399 | 9999.99% | 0.23% |
| Jan. 27, 2025 | Garg Vipin K | President and CEO | A | Stock Options (option to buy) | 477500 | $0.00 | 477,500.0000 | 71,003,399 | 9999.99% | 0.67% |
| Jan. 25, 2025 | Garg Vipin K | President and CEO | M | Restricted Stock Units | 42050 | $0.00 | 126,150.0000 | 71,003,399 | 50.00% | 0.06% |
| Jan. 25, 2025 | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 18157 | $6.98 | 315,921.0000 | 71,003,399 | 5.43% | 0.03% |
| Jan. 25, 2025 | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 14600 | $0.00 | 43,800.0000 | 71,003,399 | 50.00% | 0.02% |
| Jan. 25, 2025 | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 3862 | $6.98 | 32,288.0000 | 71,003,399 | 10.68% | 0.01% |
| Jan. 25, 2025 | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 14600 | $0.00 | 36,150.0000 | 71,003,399 | 67.75% | 0.02% |
| Jan. 27, 2025 | Roberts M Scot | Chief Scientific Officer | A | Restricted Stock Units | 63400 | $0.00 | 63,400.0000 | 71,003,399 | 9999.99% | 0.09% |
| Jan. 27, 2025 | Roberts M Scot | Chief Scientific Officer | A | Stock Options (option to buy) | 183600 | $0.00 | 183,600.0000 | 71,003,399 | 9999.99% | 0.26% |
| Jan. 25, 2025 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 14600 | $0.00 | 43,800.0000 | 71,003,399 | 50.00% | 0.02% |
| Jan. 25, 2025 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 4264 | $6.98 | 53,661.0000 | 71,003,399 | 7.36% | 0.01% |
| Jan. 25, 2025 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 14600 | $0.00 | 57,925.0000 | 71,003,399 | 33.70% | 0.02% |
| Jan. 25, 2025 | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 42050 | $0.00 | 334,078.0000 | 71,003,399 | 14.40% | 0.06% |
| Jan. 27, 2025 | Jordt Raymond M | Chief Business Officer | A | Stock Options (option to buy) | 183600 | $0.00 | 183,600.0000 | 71,003,399 | 9999.99% | 0.26% |
| Jan. 27, 2025 | Jordt Raymond M | Chief Business Officer | A | Restricted Stock Units | 63400 | $0.00 | 63,400.0000 | 71,003,399 | 9999.99% | 0.09% |
| Jan. 25, 2025 | Harris Matthew Scott | Chief Medical Officer | M | Common Stock, par value $0.0001 | 14600 | $0.00 | 69,719.0000 | 71,003,399 | 26.49% | 0.02% |
| Jan. 1, 2025 | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 9375 | $0.00 | 18,750.0000 | 71,003,399 | 33.33% | 0.01% |
| Jan. 1, 2025 | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 2485 | $7.21 | 21,550.0000 | 71,003,399 | 10.34% | 0.00% |
| Jan. 1, 2025 | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 9375 | $0.00 | 24,035.0000 | 71,003,399 | 63.95% | 0.01% |
| Nov. 11, 2024 | WEAVER GREGORY L | Chief Financial Officer | A | Stock Options (option to buy) | 225000 | $0.00 | 225,000.0000 | 71,084,787 | 9999.99% | 0.32% |
| Nov. 11, 2024 | WEAVER GREGORY L | Chief Financial Officer | A | Restricted Stock Units | 75000 | $0.00 | 75,000.0000 | 71,084,787 | 9999.99% | 0.11% |
| Sept. 26, 2024 | SAYARE MITCHEL | Director | A | Stock Options (option to buy) | 34900 | $0.00 | 34,900.0000 | 70,924,371 | 9999.99% | 0.05% |
| Sept. 26, 2024 | Schafer Klaus | Director | A | Stock Options (option to buy) | 34900 | $0.00 | 34,900.0000 | 70,924,371 | 9999.99% | 0.05% |
| Sept. 26, 2024 | GILL JOHN | Director | A | Stock Options (option to buy) | 34900 | $0.00 | 34,900.0000 | 70,924,371 | 9999.99% | 0.05% |
| Sept. 26, 2024 | Sohn Catherine A. | Director | A | Stock Options (option to buy) | 34900 | $0.00 | 34,900.0000 | 70,924,371 | 9999.99% | 0.05% |
| Sept. 26, 2024 | Jorkasky Diane | Director | A | Stock Options (option to buy) | 34900 | $0.00 | 34,900.0000 | 70,924,371 | 9999.99% | 0.05% |
| Sept. 26, 2024 | Pisano Wayne | Director | A | Stock Options (option to buy) | 34900 | $0.00 | 34,900.0000 | 70,924,371 | 9999.99% | 0.05% |
| Sept. 26, 2024 | Hodges Philip | Director | A | Stock Options (option to buy) | 34900 | $0.00 | 34,900.0000 | 70,924,371 | 9999.99% | 0.05% |
| Aug. 19, 2024 | Drutz David | Director | S | Common Stock, par value $0.0001 | 7827 | $6.93 | 41,958.0000 | 70,924,371 | 15.72% | 0.01% |
| Aug. 19, 2024 | Drutz David | Director | M | Common Stock, par value $0.0001 | 20000 | $2.60 | 49,785.0000 | 70,924,371 | 67.15% | 0.03% |
| Aug. 19, 2024 | Drutz David | Director | M | Stock Options (option to buy) | 21750 | $0.00 | 4,350.0000 | 70,924,371 | 83.33% | 0.03% |
| Aug. 19, 2024 | Drutz David | Director | M | Stock Options (option to buy) | 20000 | $0.00 | 0.0000 | 70,924,371 | 100.00% | 0.03% |
| Aug. 19, 2024 | Drutz David | Director | S | Common Stock, par value $0.0001 | 8184 | $6.88 | 55,524.0000 | 70,924,371 | 12.85% | 0.01% |
| Aug. 19, 2024 | Drutz David | Director | M | Common Stock, par value $0.0001 | 21750 | $2.50 | 63,708.0000 | 70,924,371 | 51.84% | 0.03% |
| July 31, 2024 | Harris Matthew Scott | Chief Medical Officer | A | Common Stock, par value $0.0001 | 1486 | $5.41 | 55,119.0000 | 70,924,371 | 2.77% | 0.00% |
| July 31, 2024 | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 917 | $5.41 | 14,660.0000 | 70,924,371 | 6.67% | 0.00% |
| July 31, 2024 | Shutterly Andrew | Acting Chief Financial Officer | A | Common Stock, par value $0.0001 | 1259 | $5.41 | 11,372.0000 | 70,924,371 | 12.45% | 0.00% |
| July 31, 2024 | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 650 | $5.41 | 43,325.0000 | 70,924,371 | 1.52% | 0.00% |
| Feb. 1, 2024 | Harris Matthew Scott | Chief Medical Officer | F | Common Stock, par value $0.0001 | 1801 | $9.88 | 48,190.0000 | 53,246,937 | 3.60% | 0.00% |
| Feb. 1, 2024 | Harris Matthew Scott | Chief Medical Officer | M | Common Stock, par value $0.0001 | 6166 | $0.00 | 49,991.0000 | 53,246,937 | 14.07% | 0.01% |
| Feb. 2, 2024 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 7775 | $0.00 | 15,550.0000 | 53,246,937 | 33.33% | 0.01% |
| Feb. 1, 2024 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 6166 | $0.00 | 6,166.0000 | 53,246,937 | 50.00% | 0.01% |
| Feb. 2, 2024 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2330 | $9.32 | 42,675.0000 | 53,246,937 | 5.18% | 0.00% |
| Feb. 2, 2024 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 45,005.0000 | 53,246,937 | 20.88% | 0.01% |
| Feb. 1, 2024 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 1801 | $9.88 | 37,230.0000 | 53,246,937 | 4.61% | 0.00% |
| Feb. 1, 2024 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 6166 | $0.00 | 39,031.0000 | 53,246,937 | 18.76% | 0.01% |
| Feb. 2, 2024 | Garg Vipin K | President and CEO | M | Restricted Stock Units | 18950 | $0.00 | 37,900.0000 | 53,246,937 | 33.33% | 0.04% |
| Feb. 1, 2024 | Garg Vipin K | President and CEO | M | Restricted Stock Units | 16545 | $0.00 | 16,545.0000 | 53,246,937 | 50.00% | 0.03% |
| Feb. 2, 2024 | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 8376 | $9.32 | 292,028.0000 | 53,246,937 | 2.79% | 0.02% |
| Feb. 2, 2024 | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 18950 | $0.00 | 300,404.0000 | 53,246,937 | 6.73% | 0.04% |
| Feb. 1, 2024 | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 7313 | $9.88 | 281,454.0000 | 53,246,937 | 2.53% | 0.01% |
| Feb. 1, 2024 | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 16545 | $0.00 | 288,767.0000 | 53,246,937 | 6.08% | 0.03% |
| Feb. 2, 2024 | Harris Matthew Scott | Chief Medical Officer | M | Restricted Stock Units | 7775 | $0.00 | 15,550.0000 | 53,246,937 | 33.33% | 0.01% |
| Feb. 1, 2024 | Harris Matthew Scott | Chief Medical Officer | M | Restricted Stock Units | 6166 | $0.00 | 6,166.0000 | 53,246,937 | 50.00% | 0.01% |
| Feb. 2, 2024 | Harris Matthew Scott | Chief Medical Officer | F | Common Stock, par value $0.0001 | 2332 | $9.32 | 53,633.0000 | 53,246,937 | 4.17% | 0.00% |
| Feb. 2, 2024 | Harris Matthew Scott | Chief Medical Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 55,965.0000 | 53,246,937 | 16.13% | 0.01% |
| Jan. 30, 2024 | Harris Matthew Scott | Chief Medical Officer | M | Restricted Stock Units | 9275 | $0.00 | 27,825.0000 | 53,246,937 | 25.00% | 0.02% |
| Jan. 30, 2024 | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 26775 | $0.00 | 276,030.0000 | 53,246,937 | 10.74% | 0.05% |
| Jan. 30, 2024 | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 11697 | $9.80 | 264,333.0000 | 53,246,937 | 4.24% | 0.02% |
| Jan. 31, 2024 | Garg Vipin K | President and CEO | A | Common Stock, par value $0.0001 | 7889 | $2.69 | 272,222.0000 | 53,246,937 | 2.98% | 0.01% |
| Jan. 30, 2024 | Garg Vipin K | President and CEO | M | Restricted Stock Units | 26775 | $0.00 | 80,325.0000 | 53,246,937 | 25.00% | 0.05% |
| Jan. 30, 2024 | Eisenstadt Richard I | Chief Financial Officer | M | Common Stock, par value $0.0001 | 9275 | $0.00 | 42,566.0000 | 53,246,937 | 27.86% | 0.02% |
| Jan. 30, 2024 | Eisenstadt Richard I | Chief Financial Officer | F | Common Stock, par value $0.0001 | 2175 | $9.80 | 40,391.0000 | 53,246,937 | 5.11% | 0.00% |
| Jan. 31, 2024 | Eisenstadt Richard I | Chief Financial Officer | A | Common Stock, par value $0.0001 | 4621 | $2.69 | 45,012.0000 | 53,246,937 | 11.44% | 0.01% |
| Jan. 30, 2024 | Eisenstadt Richard I | Chief Financial Officer | M | Restricted Stock Units | 9275 | $0.00 | 27,825.0000 | 53,246,937 | 25.00% | 0.02% |
| Jan. 31, 2024 | Harris Matthew Scott | Chief Medical Officer | A | Common Stock, par value $0.0001 | 3257 | $2.69 | 43,825.0000 | 53,246,937 | 8.03% | 0.01% |
| Jan. 30, 2024 | Harris Matthew Scott | Chief Medical Officer | F | Common Stock, par value $0.0001 | 2709 | $9.80 | 40,568.0000 | 53,246,937 | 6.26% | 0.01% |
| Jan. 30, 2024 | Harris Matthew Scott | Chief Medical Officer | M | Common Stock, par value $0.0001 | 9275 | $0.00 | 43,277.0000 | 53,246,937 | 27.28% | 0.02% |
| Jan. 31, 2024 | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 5030 | $2.69 | 13,743.0000 | 53,246,937 | 57.73% | 0.01% |
| Jan. 30, 2024 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 9275 | $0.00 | 27,825.0000 | 53,246,937 | 25.00% | 0.02% |
| Jan. 31, 2024 | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 5860 | $2.69 | 32,865.0000 | 53,246,937 | 21.70% | 0.01% |
| Jan. 30, 2024 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2709 | $9.80 | 27,005.0000 | 53,246,937 | 9.12% | 0.01% |
| Jan. 30, 2024 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 9275 | $0.00 | 29,714.0000 | 53,246,937 | 45.38% | 0.02% |
| Jan. 25, 2024 | Eisenstadt Richard I | Chief Financial Officer | A | Restricted Stock Units | 58400 | $0.00 | 58,400.0000 | 53,246,937 | 9999.99% | 0.11% |
| Jan. 25, 2024 | Roberts M Scot | Chief Scientific Officer | A | Stock Options (option to buy) | 163200 | $0.00 | 163,200.0000 | 53,246,937 | 9999.99% | 0.31% |
| Jan. 25, 2024 | Roberts M Scot | Chief Scientific Officer | A | Restricted Stock Units | 58400 | $0.00 | 58,400.0000 | 53,246,937 | 9999.99% | 0.11% |
| Jan. 25, 2024 | Jordt Raymond M | Chief Business Officer | A | Stock Options (option to buy) | 163200 | $0.00 | 163,200.0000 | 53,246,937 | 9999.99% | 0.31% |
| Jan. 25, 2024 | Jordt Raymond M | Chief Business Officer | A | Restricted Stock Units | 58400 | $0.00 | 58,400.0000 | 53,246,937 | 9999.99% | 0.11% |
| Jan. 25, 2024 | Harris Matthew Scott | Chief Medical Officer | A | Stock Options (option to buy) | 163200 | $0.00 | 163,200.0000 | 53,246,937 | 9999.99% | 0.31% |
| Jan. 25, 2024 | Harris Matthew Scott | Chief Medical Officer | A | Restricted Stock Units | 58400 | $0.00 | 58,400.0000 | 53,246,937 | 9999.99% | 0.11% |
| Jan. 25, 2024 | Garg Vipin K | President and CEO | A | Stock Options (option to buy) | 470000 | $0.00 | 470,000.0000 | 53,246,937 | 9999.99% | 0.88% |
| Jan. 25, 2024 | Garg Vipin K | President and CEO | A | Restricted Stock Units | 168200 | $0.00 | 168,200.0000 | 53,246,937 | 9999.99% | 0.32% |
| Jan. 25, 2024 | Eisenstadt Richard I | Chief Financial Officer | A | Stock Options (option to buy) | 163200 | $0.00 | 163,200.0000 | 53,246,937 | 9999.99% | 0.31% |
| Jan. 1, 2024 | Jordt Raymond M | Chief Business Officer | F | Common Stock, par value $0.0001 | 2503 | $11.25 | 8,704.0000 | 53,246,937 | 22.33% | 0.00% |
| Jan. 1, 2024 | Jordt Raymond M | Chief Business Officer | M | Common Stock, par value $0.0001 | 9375 | $0.00 | 11,207.0000 | 53,246,937 | 511.74% | 0.02% |
| Jan. 1, 2024 | Jordt Raymond M | Chief Business Officer | M | Restricted Stock Units | 9375 | $0.00 | 28,125.0000 | 53,246,937 | 25.00% | 0.02% |
| Dec. 29, 2023 | Eisenstadt Richard I | Chief Financial Officer | F | Common Stock, par value $0.0001 | 3044 | $11.25 | 33,291.0000 | 53,633,354 | 8.38% | 0.01% |
| Dec. 29, 2023 | Eisenstadt Richard I | Chief Financial Officer | M | Common Stock, par value $0.0001 | 12500 | $0.00 | 36,335.0000 | 53,633,354 | 52.44% | 0.02% |
| Dec. 29, 2023 | Eisenstadt Richard I | Chief Financial Officer | M | Restricted Stock Units | 12500 | $0.00 | 25,000.0000 | 53,633,354 | 33.33% | 0.02% |
| Sept. 28, 2023 | Pisano Wayne | Director | A | Stock Options (option to buy) | 26100 | $0.00 | 26,100.0000 | 50,691,558 | 9999.99% | 0.05% |
| Sept. 28, 2023 | Schafer Klaus | Director | A | Stock Options (option to buy) | 26100 | $0.00 | 26,100.0000 | 50,691,558 | 9999.99% | 0.05% |
| Sept. 28, 2023 | Drutz David | Director | A | Stock Options (option to buy) | 26100 | $0.00 | 26,100.0000 | 50,691,558 | 9999.99% | 0.05% |
| Sept. 28, 2023 | Hodges Philip | Director | A | Stock Options (option to buy) | 26100 | $0.00 | 26,100.0000 | 50,691,558 | 9999.99% | 0.05% |
| Sept. 28, 2023 | Sohn Catherine A. | Director | A | Stock Options (option to buy) | 26100 | $0.00 | 26,100.0000 | 50,691,558 | 9999.99% | 0.05% |
| Sept. 28, 2023 | GILL JOHN | Director | A | Stock Options (option to buy) | 26100 | $0.00 | 26,100.0000 | 50,691,558 | 9999.99% | 0.05% |
| Sept. 28, 2023 | SAYARE MITCHEL | Director | A | Stock Options (option to buy) | 26100 | $0.00 | 26,100.0000 | 50,691,558 | 9999.99% | 0.05% |
| Sept. 28, 2023 | Jorkasky Diane | Director | A | Stock Options (option to buy) | 26100 | $0.00 | 26,100.0000 | 50,691,558 | 9999.99% | 0.05% |
| Aug. 15, 2023 | Drutz David | Director | P | Common Stock, par value $0.0001 | 300 | $2.88 | 29,785.0000 | 50,691,558 | 1.02% | 0.00% |
| July 31, 2023 | Jordt Raymond M | Chief Business Officer | A | Common Stock, par value $0.0001 | 1832 | $2.81 | 1,832.0000 | 50,691,558 | 9999.99% | 0.00% |
| July 31, 2023 | Garg Vipin K | President and CEO | A | Common Stock, par value $0.0001 | 126 | $2.81 | 249,255.0000 | 50,691,558 | 0.05% | 0.00% |
| July 31, 2023 | Eisenstadt Richard I | Chief Financial Officer | A | Common Stock, par value $0.0001 | 1825 | $2.81 | 23,835.0000 | 50,691,558 | 8.29% | 0.00% |
| July 31, 2023 | Harris Matthew Scott | Chief Medical Officer | A | Common Stock, par value $0.0001 | 691 | $2.81 | 34,002.0000 | 50,691,558 | 2.07% | 0.00% |
| July 31, 2023 | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 568 | $2.81 | 20,439.0000 | 50,691,558 | 2.86% | 0.00% |
| Aug. 12, 2022 | GILL JOHN | Director | S | Common Stock, par value $0.0001 | 2714 | $15.00 | 2,771.0000 | 47,502,599 | 49.48% | 0.01% |
| March 23, 2023 | Sohn Catherine A. | Director | A | Stock Options (option to buy) | 47000 | $0.00 | 47,000.0000 | 46,926,349 | 9999.99% | 0.10% |
| March 23, 2023 | Drutz David | Director | P | Common Stock, par value $0.0001 | 9000 | $4.27 | 29,484.0000 | 46,926,349 | 43.94% | 0.02% |
| March 24, 2023 | Eisenstadt Richard I | Chief Financial Officer | P | Common Stock, par value $0.0001 | 10000 | $4.31 | 22,010.0000 | 46,926,349 | 83.26% | 0.02% |
| March 23, 2023 | Harris Matthew Scott | Chief Medical Officer | P | Common Stock, par value $0.0001 | 10000 | $4.22 | 33,311.0000 | 46,926,349 | 42.90% | 0.02% |
| Feb. 2, 2023 | Garg Vipin K | President and CEO | M | Restricted Stock Units | 18950 | $0.00 | 56,850.0000 | 46,926,349 | 25.00% | 0.04% |
| Feb. 2, 2023 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 22,246.0000 | 46,926,349 | 53.73% | 0.02% |
| Feb. 2, 2023 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2375 | $15.04 | 19,871.0000 | 46,926,349 | 10.68% | 0.01% |
| Feb. 2, 2023 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 7775 | $0.00 | 23,325.0000 | 46,926,349 | 25.00% | 0.02% |
| Feb. 2, 2023 | Harris Matthew Scott | Chief Medical Officer | M | Common Stock, par value $0.0001 | 7775 | $0.00 | 25,675.0000 | 46,926,349 | 43.44% | 0.02% |
| Feb. 2, 2023 | Harris Matthew Scott | Chief Medical Officer | F | Common Stock, par value $0.0001 | 2364 | $15.04 | 23,311.0000 | 46,926,349 | 9.21% | 0.01% |
| Feb. 2, 2023 | Harris Matthew Scott | Chief Medical Officer | M | Restricted Stock Units | 7775 | $0.00 | 23,325.0000 | 46,926,349 | 25.00% | 0.02% |
| Feb. 2, 2023 | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 18950 | $0.00 | 257,551.0000 | 46,926,349 | 7.94% | 0.04% |
| Feb. 2, 2023 | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 8422 | $15.04 | 249,129.0000 | 46,926,349 | 3.27% | 0.02% |
| Jan. 31, 2023 | Harris Matthew Scott | Chief Medical Officer | A | Common Stock, par value $0.0001 | 1296 | $10.21 | 13,917.0000 | 46,926,349 | 10.27% | 0.00% |
| Jan. 31, 2023 | Roberts M Scot | Chief Scientific Officer | A | Common Stock, par value $0.0001 | 1436 | $10.21 | 10,488.0000 | 46,926,349 | 15.86% | 0.00% |
| Feb. 1, 2023 | Roberts M Scot | Chief Scientific Officer | M | Common Stock, par value $0.0001 | 6166 | $0.00 | 16,654.0000 | 46,926,349 | 58.79% | 0.01% |
| Feb. 1, 2023 | Roberts M Scot | Chief Scientific Officer | F | Common Stock, par value $0.0001 | 2183 | $13.78 | 14,471.0000 | 46,926,349 | 13.11% | 0.00% |
| Feb. 1, 2023 | Roberts M Scot | Chief Scientific Officer | M | Restricted Stock Units | 6166 | $0.00 | 12,332.0000 | 46,926,349 | 33.33% | 0.01% |
| Jan. 31, 2023 | Eisenstadt Richard I | Chief Financial Officer | A | Common Stock, par value $0.0001 | 1172 | $10.21 | 12,010.0000 | 46,926,349 | 10.81% | 0.00% |
| Feb. 1, 2023 | Garg Vipin K | President and CEO | M | Restricted Stock Units | 16546 | $0.00 | 33,090.0000 | 46,926,349 | 33.33% | 0.04% |
| Feb. 1, 2023 | Garg Vipin K | President and CEO | F | Common Stock, par value $0.0001 | 7658 | $13.78 | 238,601.0000 | 46,926,349 | 3.11% | 0.02% |
| Feb. 1, 2023 | Garg Vipin K | President and CEO | M | Common Stock, par value $0.0001 | 16546 | $0.00 | 246,259.0000 | 46,926,349 | 7.20% | 0.04% |
| Jan. 31, 2023 | Garg Vipin K | President and CEO | A | Common Stock, par value $0.0001 | 1938 | $10.21 | 229,713.0000 | 46,926,349 | 0.85% | 0.00% |
| Feb. 1, 2023 | Harris Matthew Scott | Chief Medical Officer | M | Restricted Stock Units | 6166 | $0.00 | 12,332.0000 | 46,926,349 | 33.33% | 0.01% |
| Feb. 1, 2023 | Harris Matthew Scott | Chief Medical Officer | F | Common Stock, par value $0.0001 | 2183 | $13.78 | 17,900.0000 | 46,926,349 | 10.87% | 0.00% |
| Feb. 1, 2023 | Harris Matthew Scott | Chief Medical Officer | M | Common Stock, par value $0.0001 | 6166 | $0.00 | 20,083.0000 | 46,926,349 | 44.31% | 0.01% |
| Jan. 30, 2023 | Eisenstadt Richard I | Chief Financial Officer | A | Stock Options (option to buy) | 105000 | $0.00 | 105,000.0000 | 46,926,349 | 9999.99% | 0.22% |
| Jan. 30, 2023 | Roberts M Scot | Chief Scientific Officer | A | Restricted Stock Units | 37100 | $0.00 | 37,100.0000 | 46,926,349 | 9999.99% | 0.08% |
| Jan. 30, 2023 | Roberts M Scot | Chief Scientific Officer | A | Stock Options (option to buy) | 105000 | $0.00 | 105,000.0000 | 46,926,349 | 9999.99% | 0.22% |
| Jan. 30, 2023 | Garg Vipin K | President and CEO | A | Restricted Stock Units | 107100 | $0.00 | 107,100.0000 | 46,926,349 | 9999.99% | 0.23% |
| Jan. 30, 2023 | Garg Vipin K | President and CEO | A | Stock Options (option to buy) | 302900 | $0.00 | 302,900.0000 | 46,926,349 | 9999.99% | 0.65% |
| Jan. 30, 2023 | Harris Matthew Scott | Chief Medical Officer | A | Restricted Stock Units | 37100 | $0.00 | 37,100.0000 | 46,926,349 | 9999.99% | 0.08% |
| Jan. 30, 2023 | Harris Matthew Scott | Chief Medical Officer | A | Stock Options (option to buy) | 105000 | $0.00 | 105,000.0000 | 46,926,349 | 9999.99% | 0.22% |
| Jan. 30, 2023 | Eisenstadt Richard I | Chief Financial Officer | A | Restricted Stock Units | 37100 | $0.00 | 37,100.0000 | 46,926,349 | 9999.99% | 0.08% |
| Jan. 3, 2023 | Jordt Raymond M | Chief Business Officer | A | Restricted Stock Units | 37500 | $0.00 | 37,500.0000 | 46,926,349 | 9999.99% | 0.08% |
| Jan. 3, 2023 | Jordt Raymond M | Chief Business Officer | A | Stock Options (option to buy) | 125000 | $0.00 | 125,000.0000 | 46,926,349 | 9999.99% | 0.27% |
| Dec. 31, 2022 | Eisenstadt Richard I | Chief Financial Officer | M | Restricted Stock Units | 12500 | $0.00 | 37,500.0000 | 49,286,535 | 25.00% | 0.03% |
| Dec. 31, 2022 | Eisenstadt Richard I | Chief Financial Officer | F | Common Stock, par value $0.0001 | 3028 | $16.45 | 10,838.0000 | 49,286,535 | 21.84% | 0.01% |
| Dec. 31, 2022 | Eisenstadt Richard I | Chief Financial Officer | M | Common Stock, par value $0.0001 | 12500 | $0.00 | 13,866.0000 | 49,286,535 | 915.08% | 0.03% |